Figure 2From: Efficacy, safety and tolerability of tofacitinib in patients with an inadequate response to disease modifying anti-rheumatic drugs: a meta-analysis of randomized double-blind controlled studies Mantel-Haenszel odds ratio of at least a 20% improvement in the American College of Rheumatology scale (ACR 20). Back to article page